 The subject has a type of lymph gland disease called Hodgkin Disease HD or non-Hodgkin Lymphoma NHL, TNK-lymphoproliferative disease or severe chronic active Epstein Barr Virus CAEBV which has come back, is at risk of coming back, or has not gone away after treatment, including the best treatment we know for these diseases. This research study uses special immune system cells called LMP, BARF-1 and EBNA1- specific cytotoxic T lymphocytes MABEL CTLs. 